Mansoor - Medicina interna- Enfoque basado en problemas, 1ed

53

Capítulo 4 | INSUFICIENCIA CARDIACA

REFERENCIAS 1. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation . 2013;128(16):1810-1852. 2. Volpe M, McKelvie R, Drexler H. Hypertension as an underlying factor in heart failure with preserved ejection fraction. J Clin Hypertens . 2010;12(4):277-283. 3. Mensah YB, Mensah K, Asiamah S, et al. Establishing the cardiothoracic ratio using chest radiographs in an indigenous Ghanaian popula- tion: a simple tool for cardiomegaly screening. Ghana Med J . 2015;49(3):159-164. 4. Inamdar AA, Inamdar AC. Heart failure: diagnosis, management and utilization. J Clin Med . 2016;5(7). 5. Tavel ME. Clinical Phonocardiography and External Pulse Recording . 2nd ed. Chicago, IL: Year Book Medical Publishers, Inc.; 1967. 6. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America. Circulation . 2017. 7. Briceno N, Schuster A, Lumley M, Perera D. Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation. Heart . 2016;102(5):397-406. 8. Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation . 2009;119(18):2516-2525. 9. Ellis ER, Josephson ME. What about tachycardia-induced cardiomyopathy? Arrhythm Electrophysiol Rev . 2013;2(2):82-90. 10. Marriott HJL. Bedside Cardiac Diagnosis . Philadelphia, PA: Lippincott Company; 1993. 11. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet . 2009;373(9672):1382-1394. 12. Stern AB, Klemmer PJ. High-output heart failure secondary to arteriovenous fistula. Hemodial Int . 2011;15(1):104-107. 13. Won S, Hong RA, Shohet RV, Seto TB, Parikh NI. Methamphetamine-associated cardiomyopathy. Clin Cardiol . 2013;36(12):737-742. 14. Groarke JD, Nohria A. Anthracycline cardiotoxicity: a new paradigm for an old classic. Circulation . 2015;131(22):1946-1949. 15. Merce J, Ferras S, Oltra C, et al. Cardiovascular abnormalities in hyperthyroidism: a prospective Doppler echocardiographic study. Am J Med . 2005;118(2):126-131. 16. Benziger CP, do Carmo GA, Ribeiro AL. Chagas cardiomyopathy: clinical presentation and management in the Americas. Cardiol Clin . 2017;35(1):31-47. 17. Remick J, Georgiopoulou V, Marti C, et al. Heart failure in patients with human immunodeficiency virus infection: epidemiology, patho- physiology, treatment, and future research. Circulation . 2014;129(17):1781-1789. 18. Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocar- ditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J . 2013;34(33):2636-2648, 2648a-2648d. 19. Sato R, Nasu M. A review of sepsis-induced cardiomyopathy. J Intensive Care . 2015;3:48. 20. Mestroni L, Maisch B, McKenna WJ, et al. Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J . 1999;20(2):93-102. 21. Givertz MM. Cardiology patient page: peripartum cardiomyopathy. Circulation . 2013;127(20):e622-e626. 22. Marinescu V, McCullough PA. Nutritional and micronutrient determinants of idiopathic dilated cardiomyopathy: diagnostic and thera- peutic implications. Expert Rev Cardiovasc Ther . 2011;9(9):1161-1170. 23. Verhaert D, Richards K, Rafael-Fortney JA, Raman SV. Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Circ Cardiovasc Imaging . 2011;4(1):67-76. 24. Kandolin R, Lehtonen J, Salmenkivi K, Raisanen-Sokolowski A, Lommi J, Kupari M. Diagnosis, treatment, and outcome of giant-cell myo- carditis in the era of combined immunosuppression. Circ Heart Fail . 2013;6(1):15-22. 25. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopa- thy. N Engl J Med . 2000;342(15):1077-1084. 26. Tarazi RC, Levy MN. Cardiac responses to increased afterload. State-of-the-art review. Hypertension . 1982;4(3 Pt 2):8-18. 27. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (wri­ ting committee to develop guidelines for the management of adults with congenital heart disease). Circulation . 2008;118(23):2395-2451. 28. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol . 2014;63(22):e57-185. 29. Carabello BA. Modern management of mitral stenosis. Circulation . 2005;112(3):432-437. 30. Mansoor AM, Mansoor SE. Images in clinical medicine. Lancisi’s Sign. N Engl J Med . 2016;374(2):e2. 31. Almeda FQ, Kavinsky CJ, Pophal SG, Klein LW. Pulmonic valvular stenosis in adults: diagnosis and treatment. Catheter Cardiovasc Interv . 2003;60(4):546-557. 32. Burgess TE, Mansoor AM. Giant a waves. BMJ Case Rep . 2017;2017. 33. Banypersad SM, Moon JC, Whelan C, Hawkins PN, Wechalekar AD. Updates in cardiac amyloidosis: a review. J Am Heart Assoc . 2012;1(2):e000364. 34. HassanW, Al-Sergani H, MouradW, Tabbaa R. Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and mana­ gement. Tex Heart Inst J . 2005;32(2):178-184. 35. Ginsberg F, Parrillo JE. Eosinophilic myocarditis. Heart Fail Clin . 2005;1(3):419-429. 36. Valent P, Klion AD, Horny HP, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol . 2012;130(3):607-612.e9. 37. Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol . 2014;64(1):83-99. SAMPLE

CARDIOLOGÍA